Merck Serono Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients. FDA Gives Guardant Health IDE Approval for Clinical Trial of Merck KGaA Cancer Drug Guardant is providing its Guardant 360 CDx test for a clinical trial of Merck's small molecule, c-Met kinase inhibitor called tepotinib. Illumina, Merck Serono to Develop Universal NGS-based Oncology Dx The collaboration adds to a similar agreement Illumina struck with AstraZeneca, Janssen Biotech, and Sanofi last year. Spanish Cancer Institute Using Sysmex Inostics, Merck Serono Blood Dx to Study mCRC Personalized Rx Premium Vall d'Hebron's Institute of Oncology will use the liquid biopsy-based OncoBEAM RAS test to research precision medicine approaches for metastatic colorectal cancer patients. Comparison Shows Life Tech CastPCR Provides Equivalent Results to Therascreen for KRAS Detection Premium The customizable PCR plates may also be less expensive than the FDA-approved Therascreen kits. Jun 3, 2014 Merck KGaA, Sysmex Inostics Partner on Development of CRC Biomarker Test Jul 17, 2013 Merck Enlists Life Tech to Develop Companion Test for Cancer Drug, Other Pipeline Opportunities Premium Jul 16, 2013 Life Tech Inks Companion Dx Alliance with Merck Serono Sep 7, 2012 Merck Serono Spinoff Quartz Bio to Offer Specialized Biomarker Analysis Services to Pharma Premium Sep 3, 2012 Merck Serono Spins Out Bioinformatics Firm Jul 11, 2012 Merck KGaA, MDxHealth Explore Personalized Rx Strategy for Glioblastoma Patients with Methylated MGMT Premium Jul 3, 2012 Merck Serono, Compugen Form Joint Venture to Develop Genomic Tests for Drug-Induced Toxicity Premium Jun 25, 2012 Merck Serono, Compugen Form Biomarker Discovery Firm May 2, 2012 Merck Serono Survey Finds Limited Test Access, High Costs a Barrier to Personalized Rx Adoption in UK Premium Jan 20, 2011 Lead Discovery Center, Merck Partner on Kinase Inhibitor Discovery Jun 9, 2010 ASCO Reviewer Advises Genotyping to Improve Success for MEK-Inhibiting Cancer Drugs Premium Jun 10, 2009 BioSeek Extends Merck Profiling Plan to 2012 Mar 30, 2009 BioRegion Real Estate: Mar 30, 2009 Premium Mar 25, 2009 Tech Transfer Tidbits: Mar 25, 2009 Premium Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.